drop semaglutide 💊 Exciting News! We're now

GLP-1 users are consuming fewer calories, so they need nutrient-dense products to meet their nutritional needs

It is a non-invasive procedure and has no associated downtime

For weight management specifically, comparisons should reference the higher 2.4 mg dose of semaglutide (Wegovy) rather than the 1 mg dose used for diabetes

The SURMOUNT-1 trial showed that FDA-approved tirzepatide produced average weight loss of 15% at 5mg, 19.5% at 10mg, and 20.9% at 15mg over 72 weeks

Nonetheless, the present data support mimicry of the physiological function of circulating adiponectin by metformin, which controls incretin-mediated hypoglycemic episodes